Leg pain: a sign of a heart attack or not?

When there is a problem with the blood arteries or the heart is not pumping properly, leg pain associated with cardiac issues may manifest. This often occurs because one of the coronary arteries, which carry blood to the heart, is blocked.

Leg discomfort is not typically thought of as a heart attack sign by experts. Leg pain, however, can also be a sign of other heart problems.

Symptoms of a heart attack include:

Other cardiac issues that may result in leg pain

Venous thrombosis embolism

A narrowing or obstruction in the arteries supplying blood to the extremities, mainly the legs, causes PAD, a cardiovascular disorder. Atherosclerosis, a disorder where plaque deposits accumulate within the artery walls, is the cause of this restriction.

Symptoms of inadequate blood flow to the legs include:

  • pain or aching in the legs
  • heaviness in the legs
  • loss of leg hair
  • pale, blue, or discolored legs or feet

Congenital heart defect

CHDs are structural cardiac defects that are present at birth. They are able to alter regular blood. The most frequent birth defect is CHD. They have an impact on about 1%Trusted Source of live births in the US.CHDs come in a variety of forms. The majority of them have an impact on the heart's major blood arteries, valves, and internal walls. The severity, kind, and age of the defect, as well as the patient's age, all affect the symptoms connected with a CHD.

Typical signs include:

  • bluish tint to the skin and lips
  • constant fatigue
  • heart murmurs

How do physicians identify cardiac issues that cause leg pain?

A complete medical history and physical examination are often conducted first to evaluate symptoms, risk factors, and general health in order to determine whether a heart issue is the source of leg discomfort.

 Ankle-brachial index (ABI) measurements, which monitor blood pressure in the arms and legs, are a type of diagnostic test that can be used to assess blood flow and spot potential blockages.

A doctor may use imaging studies to better see the blood vessels and look for any anomalies that might be causing leg pain or underlying cardiac problems. These imaging exams consist of:

To know more information visit https://www.cardiology.scientexconference.com/

Comments

Post a Comment

Popular posts from this blog

Image
  Ventricular Assist Device – Miniature The treatment of individuals with severe heart failure has been transformed by the development of a ventricular assist device (VAD). When a donor heart cannot be identified, the VAD, which was initially designed as a bridge to transplantation , has been proved to extend life and improve quality of life. Older models needed patients to ambulate with hefty , huge external batteries and control devices and required the implantation of a big pump. Yet in the upcoming years, a number of ground-breaking advancements in device size , battery life, and even wireless charging technologies may render these devices physically undetectable and possibly reduce patient vulnerability to infections. The rates of haemolysis, thrombosis, and secondary aortic valve insufficiency have also been constrained by numerous mechanical improvements and newer operating paradigms. Cardiac Decellularization and Engineered Heart Tissue Promising new direction...
Read more
Image
Myocardial infarction events involving morality, incredibly high temperatures, and minute particles.  Myocardial infarction (MI) morbidity has been connected to extreme temperature events (ETEs), such as heat wave and cold spell, but their effects on MI mortality are less well understood. Although ambient fine particulate matter (PM2.5) and severe temperatures may work in concert to increase cardiovascular mortality , it is still unclear whether or how ETEs and PM2.5 interact to cause MI deaths.METHODS: To examine the relationship between exposure to ETEs and PM2.5 and MI mortality and assess their interacting effects, a time-stratified case-crossover study of 202 678 MI deaths in Jiangsu province, China, from 2015 to 2020 was conducted. Twelve ETE definitions were created using a variety of temperature thresholds and durations based on the perceived ambient temperature. In order to estimate daily ETEs and PM2.5exposures , values were taken from validated grid datasets at reside...
Read more

New Drug Nearly Eradicates “Stealth” Cholesterol (Lp(a)) – A Game‑Changer in Heart Disease Prevention

Image
A recent clinical trial reported in the New England Journal of Medicine and showcased at the American College of Cardiology revealed that lepodisiran—an experimental RNA-targeting drug—can reduce lipoprotein(a) [Lp(a)] by nearly 100% after a single dose, with sustained effects over a year 🔍 What You Need to Know Lp(a) is a genetically determined, stealth cholesterol that significantly raises the risk of heart attacks and strokes yet is not addressed by diet or standard statins. The Phase 2 trial, involving 320 participants across 10 countries, showed almost total Lp(a) suppression at 6 months, maintained at 1 year. Reported side effects were mild, primarily limited to injection-site reactions. No serious safety issues were found.                      🌍 Why This Matters This breakthrough could pave the way for targeted Lp(a) therapies—potentially reducing cardiovascular risk in over 1.4 billion people globally with elevated levels....
Read more